Increased lysis of melanoma by in vivo-elicited human lymphokine-activated killer cells after addition of antiganglioside antibodies in vitro. [electronic resource]
Producer: 19901019Description: 6311-5 p. digitalISSN:- 0008-5472
- Antibodies, Monoclonal -- administration & dosage
- Antibody Specificity
- Antibody-Dependent Cell Cytotoxicity -- immunology
- Antigens, Neoplasm
- Antigens, Surface -- immunology
- Gangliosides -- immunology
- Humans
- Immunotherapy -- methods
- Killer Cells, Lymphokine-Activated -- immunology
- Melanoma -- immunology
- Melanoma-Specific Antigens
- Neoplasm Proteins -- immunology
- Tumor Cells, Cultured
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.